Ticho Barry sold $190K of STOK
Ticho Barry (CHIEF MEDICAL OFFICER) sold 7,195 shares of Stoke Therapeutics, Inc. (STOK) at an average of $26.40 ($26.38–$26.99, $0.19M total) across 2 trades on 2026-11-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest in size but provides fresh data on insider sentiment.
Market read
New insider sale information may influence short‑term trading decisions for STOK.
What to watch
Potential upcoming clinical milestones for Stoke Therapeutics may offset short‑term pressure.
Background
SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.
Ticker impact
Chief Medical Officer Ticho Barry sold 7,195 shares for $189,912 via a 10b5‑1 plan, reducing his stake to 11,864 shares.
likely slight downward pressure as the market prices in the insider sell
A recent Form 4 filing shows a C‑suite insider disposing of nearly $190 k of stock, which typically signals limited confidence and can prompt short‑term price softness.
Market effects
none
none
none
Counterpoint
The sale could be routine liquidity management and not indicative of future performance.
Key entities
- companyStoke Therapeutics, Inc.
Biopharma company developing therapeutic candidates.
- personTicho Barry
Chief Medical Officer of Stoke Therapeutics.

